All articles by Srijanee Chakraborthy

Srijanee Chakraborthy

New study finds benzodiazepines use increases stroke risk in people with Alzheimer’s disease

A new study from the University of Eastern Finland has found the use of drugs such as benzodiazepine and benzodiazepine-like drugs was related to a 20% increased risk of stroke in patients with Alzheimer’s disease.

BTG launches DC Bead LUMI for liver cancer patients in Canada

BTG International has launched a next-generation treatment option, DC Bead LUMI, for cancer patients in Canada, marking its first worldwide market commercialisation.

New Myeloma Genome Project established to advance diagnosis and treatments

Celgene, the Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences have collaboratively launched a new initiative known as the Myeloma Genome Project.

New research finds 74% of UK public support test before antibiotic prescriptions

New research published by Longitude Prize has revealed that nearly 74% of the UK public support a compulsory test for bacterial infection before deciding to seek out antibiotics.

Eli Lilly secures conditional marketing authorisation for olaratumab injection with doxorubicin

The European Commission (EC) has granted conditional marketing authorisation for Eli Lilly and Company’s (LLY) olaratumab injection of 10mg/ml in combination with doxorubicin, to treat adults with advanced soft tissue sarcoma (STS) who are not suited for curative surgery or radiotherapy and were not previously treated with doxorubicin.

Scintilla Pharmaceuticals completes acquisition of majority share in SCILEX

US-based clinical-stage biopharmaceutical company Sorrento’s subsidiary Scintilla Pharmaceuticals has completed acquiring the majority share of pharmaceutical products developer SCILEX.

BenevolentAI signs exclusive license agreement with Janssen for clinical-stage drugs

British artificial intelligence (AI) company BenevolentAI has signed an exclusive license for a series of clinical-stage drug candidates with Janssen Pharmaceutica (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Lonza opens drug product services laboratory in Switzerland

Chemicals and biotechnology company Lonza has opened its pharmaceutical Drug Product Services laboratory in the Stücki Science Park Basel (CH), Switzerland.

Merck and American Cancer Society release report on cancer death in women

Merck and the American Cancer Society (ACS) have released a report on causes of cancer-related mortality in women.

Valeant reportedly holding talks to divest gastrointestinal treatment specialist business

Valeant Pharmaceuticals is reportedly holding advanced talks to divest its gastrointestinal treatment specialist business to Japanese firm Takeda Pharmaceutical for approximately $10bn.